Curis Teams Up With LLS To Fund Early-Stage Research
This article was originally published in The Pink Sheet Daily
Executive Summary
Lexington, Mass-based Curis landed up to $4 million in funding from The Leukemia & Lymphoma Society to help develop its preclinical treatment for B-cell lymphoma and multiple myeloma.